Cargando…

The Impact of THC and CBD in Schizophrenia: A Systematic Review

Background: People with schizophrenia are more likely to develop cannabis use disorder (CUD) and experience worse outcomes with use. Yet as cannabis is legalized for medical and recreational use, there is interest in its therapeutic potential. Objectives: To conduct a systematic review summarizing t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Saeed, Roth, Robert M., Stanciu, Corneliu N., Brunette, Mary F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343183/ https://www.ncbi.nlm.nih.gov/pubmed/34366924 http://dx.doi.org/10.3389/fpsyt.2021.694394

Ejemplares similares

CBD, a precursor of THC in e-cigarettes
por: Czégény, Zsuzsanna, et al.
Publicado: (2021)

Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats
por: Gabaglio, Marina, et al.
Publicado: (2021)

A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆(9)-tetrahydrocannabinol (THC) by vaporisation
por: Solowij, Nadia, et al.
Publicado: (2014)

A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC
por: Kim, Seok Hee, et al.
Publicado: (2019)

Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot
por: Pennypacker, Sarah D., et al.
Publicado: (2022)

THC and CBD: Villain versus Hero? Insights into Adolescent Exposure
por: Pintori, Nicholas, et al.
Publicado: (2023)

Effects of Adolescent THC Exposure on the Prefrontal GABAergic System: Implications for Schizophrenia-Related Psychopathology
por: Renard, Justine, et al.
Publicado: (2018)

Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
por: Lachenmeier, Dirk W., et al.
Publicado: (2023)

Nanomaterials-Based Electrochemical Δ(9)-THC and CBD Sensors for Chronic Pain
por: Pazuki, Dadbeh, et al.
Publicado: (2023)

POTENTIAL BENEFITS OF THC AND CBD IN THE TREATMENT OF HOSPICE-ELIGIBLE DEMENTED AND AGITATED PATIENTS
por: Mintzer, Jacobo`
Publicado: (2022)

Case Report: CBD Cigarettes for Harm Reduction and Adjunctive Therapy in a Patient With Schizophrenia and Substance Use Disorder
por: Meyer, Maximilian, et al.
Publicado: (2021)

Investigating how nitrogen nutrition and pruning impacts on CBD and THC concentration and plant biomass of Cannabis sativa
por: Dilena, Enrico, et al.
Publicado: (2023)

A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain
por: Überall, Michael A
Publicado: (2020)

Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC
por: Oultram, Jackson M. J., et al.
Publicado: (2021)

Delta-8-THC association with psychosis: A case report with literature review
por: Miller, Chelsea R., et al.
Publicado: (2023)

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
por: Hutten, Nadia R. P. W., et al.
Publicado: (2022)

Vape shop owners’/managers’ attitudes about CBD, THC, and marijuana legal markets
por: Berg, Carla J., et al.
Publicado: (2020)

A case report of CBD and THC as analgesic therapy in a cat with chronic osteoarthritic pain
por: Gutierre, E, et al.
Publicado: (2023)

Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
por: Niesink, Raymond J. M., et al.
Publicado: (2013)

Rapid Distinction and Semiquantitative Analysis of THC and CBD by Silver-Impregnated Paper Spray Mass Spectrometry
por: Huang, Si, et al.
Publicado: (2021)

The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis‐related spasticity
por: Celius, Elisabeth G., et al.
Publicado: (2018)

A prospective open‐label trial of a CBD/THC cannabis oil in dravet syndrome
por: McCoy, Bláthnaid, et al.
Publicado: (2018)

Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
por: Golombek, Patricia, et al.
Publicado: (2020)

Acute effects of naturalistic THC vs. CBD use on recognition memory: a preliminary study
por: Curran, Tim, et al.
Publicado: (2020)

Rapid In Situ Detection of THC and CBD in Cannabis sativa L. by 1064 nm Raman Spectroscopy
por: Porcu, Stefania, et al.
Publicado: (2022)

Differential inflammatory profile in the lungs of mice exposed to cannabis smoke with varying THC:CBD ratio
por: Haidar, Zahraa, et al.
Publicado: (2023)

The Effect of Orally Administered Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on Obesity Parameters in Mice
por: Eitan, Adi, et al.
Publicado: (2023)

A physical and genetic map of Cannabis sativa identifies extensive rearrangements at the THC/CBD acid synthase loci
por: Laverty, Kaitlin U., et al.
Publicado: (2019)

A Multiple Correspondence Analysis of Patterns of CBD Use in Hemp and Marijuana Users
por: Vilches, Joseph R., et al.
Publicado: (2021)

Dose-Related Inhibition of Capsaicin Responses by Cannabinoids CBG, CBD, THC and their Combination in Cultured Sensory Neurons
por: Anand, Uma, et al.
Publicado: (2021)

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
por: Arkell, Thomas R., et al.
Publicado: (2019)

Direct In Vivo Analysis of CBD- and THC-Acid Cannabinoids and Classification of Cannabis Cultivars Using SpiderMass
por: Ogrinc, Nina, et al.
Publicado: (2022)

Cannabidiol (CBD) in the Self-Treatment of Depression-Exploratory Study and a New Phenomenon of Concern for Psychiatrists
por: Wieckiewicz, Gniewko, et al.
Publicado: (2022)

Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review
por: Cooray, R., et al.
Publicado: (2020)

Do Cannabis Users Reduce Their THC Dosages When Using More Potent Cannabis Products? A Review
por: Leung, Janni, et al.
Publicado: (2021)

Motor neuron development in zebrafish is altered by brief (5-hr) exposures to THC (∆(9)-tetrahydrocannabinol) or CBD (cannabidiol) during gastrulation
por: Ahmed, Kazi T., et al.
Publicado: (2018)

The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC:CBD oromucosal spray)
por: Grimaldi, Alessandro Enrico, et al.
Publicado: (2019)

THC and CBD Fingerprinting of an Elite Cannabis Collection from Iran: Quantifying Diversity to Underpin Future Cannabis Breeding
por: Mostafaei Dehnavi, Mahboubeh, et al.
Publicado: (2022)

THC and CBD affect metabolic syndrome parameters including microbiome in mice fed high fat-cholesterol diet
por: Gorelick, Jonathan, et al.
Publicado: (2022)

Controlled human drug administration studies are necessary to define the THC-sparing effects of CBD and other cannabis constituents
por: Pabon, Elisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uc800vg4uva93aqfj1o6i7lvjl